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Pre-mRNA editing involving the conversion of adenosine to inosine is mediated by adenosine deaminases
that act on RNA (ADAR1 and ADAR2). ADARs contain multiple double-stranded RNA(dsRNA)-binding
domains in addition to an adenosine deaminase domain. An adenosine deaminase acting on tRNAs, scTad1p
(also known as scADAT1), cloned from Saccharomyces cerevisiae has a deaminase domain related to the ADARs
but lacks dsRNA-binding domains. We have identified a gene homologous to scADAT1 in the region of
Drosophila melanogaster Adh chromosome II. Recombinant Drosophila ADAT1 (dADAT1) has been expressed in
the yeast Pichia pastoris and purified. The enzyme has no activity on dsRNA substrates but is a tRNA
deaminase with specificity for adenosine 37 of insect alanine tRNA. dADAT1 shows greater similarity to
vertebrate ADARs than to yeast Tad1p, supporting the hypothesis of a common evolutionary origin for ADARs
and ADATs. dAdat1 transcripts are maternally supplied in the egg. Zygotic expression is widespread initially
and later concentrates in the central nervous system.
Adenosine and cytosine have exocyclic amino groups that
participate in Watson-Crick base pairing during transcription
and translation. RNA editing enzymes have been discovered
that deaminate specific adenosine residues to inosine (4, 32,
38, 40) or specific cytosine residues to uridine in RNA mole-
cules (11, 39). This can result in the incorporation of different
amino acids at edited positions or the formation of a smaller
protein due to the generation of a stop codon. Two closely
related adenosine deaminases acting on RNA (ADARs) have
been identified in vertebrates (3) that catalyze the deamination
of specific adenosine residues to inosine in pre-mRNAs (for a
review, see reference 22). These enzymes have homologous
adenosine deaminase domains (32) and also contain multiple
double-stranded RNA(dsRNA)-binding domains (47). ADARs
recognize and deaminate specific adenosines within exons that
form duplexes with flanking intronic sequences in pre-mRNA
(20, 32). ADAR activity is ubiquitous and has been found in all
metazoans tested and in most tissues (52). The abundance of
inosine in polyA1 RNA has been estimated to be 1 in 17,000
nucleotides in brain and less in other mammalian tissues, cor-
relating with ADAR expression levels (35). Inosine in edited
transcripts directs the incorporation of cytosine during first-
strand synthesis of cDNA (5), and RNA editing events have
usually been identified in cDNA sequences in which guanosine
replaces a genomically encoded adenosine (8, 45). Pre-mRNAs
encoding subunits of the glutamate-gated ion channels (for a
review, see reference 42) and the G protein-coupled serotonin
2C receptor (8) undergo RNA editing of their sequences by
this mechanism. Proteins encoded by edited mRNAs often
have functional properties that differ from the genomically
encoded versions.
Inosine was first observed as a noncanonical base occurring
in a number of tRNAs (21). Inosine in tRNAs is generated by
deamination of genomically encoded adenosine (2). Inosine
occurs at position 34 in the anticodon in a number of different
tRNAs (for a review, see reference 17). Eukaryotic alanine
tRNA (tRNAAla), containing the anticodon IGC, is the only
class of tRNA that undergoes deamination of adenosine to
inosine at position 37 adjacent to the anticodon (17). This
inosine is subsequently methylated by an as-yet-uncharacter-
ized enzyme (2). Recently, it has been found that inosine at
position 34 and methylinosine at position 37 are major epitopes
for anti-PL-12 myositis autoantibodies (6). An adenosine
deaminase acting on tRNA (ADAT1) catalyzing the site-spe-
cific deamination of adenosine at position 37 in yeast tRNAAla
has been cloned and characterized (15). This ADAT1 from
Saccharomyces cerevisiae, named scTad1p (or scADAT1) and
encoded by the TAD1 gene, is homologous to the ADARs
throughout its sequence and has three characteristic adenosine
deaminase motifs containing residues thought to chelate zinc
and contribute to catalysis in the active site of the enzymes (9).
Gerber et al. (15) have proposed that ADARs involved in
pre-mRNA editing have a common evolutionary origin with
ADATs involved in the modification of tRNAAla at position
37. These adenosine deaminase domains are also related to a
cytosine deaminase involved in mRNA editing (APOBEC) and
to cytidine deaminases involved in the deamination of free
nucleosides (9).
Embryonic nuclear extracts from Drosophila melanogaster
contain an ADAR-like activity that converts adenosine to ino-
sine in the antigenome RNA of hepatitis D virus (10). Editing
of mRNAs has been proposed to occur in Drosophila, based on
the detection of variant cDNAs having adenosine-to-guanosine
substitutions in mRNAs encoded by the 4f-rnp gene (37), the
cacophony (cac) gene (36, 44), and the paralytic (para) gene
(18). We describe here the cloning and characterization of a
gene encoding an adenosine deaminase from D. melanogaster
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that is similar to vertebrate ADARs but lacks dsRNA-binding
domains. Characterization of a purified recombinant protein
shows that this protein is a tRNA-specific adenosine deami-
nase. This protein, dADAT1, has a higher degree of amino
acid sequence homology to the ADARs than the previously
characterized yeast ADAT1. These findings support an evolu-
tionary relationship between pre-mRNA editing and tRNA
modification.
MATERIALS AND METHODS
Oligonucleotides used in this study. The oligonucleotides used in this study
are as follows: DRSB (59 GGATCCGGAACAAAGTGCATTG 39), DRSH (59
AAGCTTAAATGTCCTACAATCGA 39), hADAT181R (59 CGTTCCATCGG
GCCATCTTGTCAC 39), hADAT585R (59 TCTGGAATAATCTGAAGAGT
CCAC 39), lgt10 (59 AGCAAGTTCAGCCTGGTTAAGT 39), lgt10d (59 CGA
GCTGCTCTATAGACTGCTG 39), DRS2 (59 CCGCAATTTCCTTAACAG
39), DRS3 (59 CGGCATGGGAATCATTCAGGATGA 39), ADAT1 (59 CTTT
GTTCCGCATCCAAGCG 39), and (dC)13 adapter (59 GACTCGAGTCGAC
ATCGCCCCCCCCCCCCC 39).
Isolation of cDNA clones and sequencing. The P1 clone DS00941, sequenced
by the Berkeley Drosophila Genome Project (BDGP), carries an open reading
frame (ORF) (BG:DS00941.2) with homology to the deaminase domains of
mammalian ADAR1 and ADAR2. A 600-nucleotide fragment encoding this
homologous domain was amplified from genomic DNA by PCR. The PCR
primers (DRSB and DRSH) were designed to introduce the restriction sites
BamHI and HindIII at the 59 and 39 ends, respectively, of the PCR product which
was subcloned into the polylinker of pBluescript KS(2) (Stratagene) at these
sites (see Fig. 1). This 600-nucleotide fragment was sequenced with a Dye
Terminator Cycle Sequencing Ready Reaction kit (Perkin-Elmer) and used to
screen a lgt10 (3- to 12-h embryo) cDNA library. Nitrocellulose filters were
hybridized overnight at 65°C as previously described (50) with minor modifica-
tions. The hybridization buffer contained 63 SSC (13 SSC is 0.15 M NaCl plus
0.015 M sodium citrate), 53 Denhardt’s solution, 0.5% sodium dodecyl sulfate
(SDS), sonicated salmon sperm DNA (100 mg/ml), and approximately 2 3 105
cpm of denatured probe per ml. The filters were washed twice for 15 min in 23
SSC and 0.1% SDS at room temperature, followed by two 15-min washes at 68°C
in 0.1% SSC and 0.5% SDS. One full-length positive clone (clone 12) was
obtained (see Fig. 1). A second shorter clone (clone H) isolated from a lZAP (4-
to 8-h embryo) cDNA library (Stratagene) was also analyzed (see Fig. 1). Both
clones were sequenced with a Dye Terminator Cycle Sequencing Ready Reac-
tion kit on an Applied Biosystems 373A sequencer.
A human homologue to the dAdat1 gene was identified in the Washington
University expressed sequence tag (EST) database in a BLAST search with S.
cerevisiae ADAT1. This clone (embl/AA161179/HSAA61179), isolated from a
Stratagene human neuron library, was obtained from the IMAGE consortium
(26). Further sequencing of this 1.9-kb cDNA clone indicated that the sequence
in the database was from the 59 end of the clone and that the region encoding the
amino terminus was missing. In order to obtain additional 59 coding sequence,
PCR amplification was performed on a human fetal brain cDNA library (Clon-
tech) with lgt10d and an hADAT reverse primer, hADAT585R. Individual
gel-purified PCR products from the first round of amplification were amplified
again with a nested vector primer, lgt10, and an hADAT-specific primer,
hADAT181R. The resulting PCR products were sequenced directly to complete
the coding sequence. A BLAST search with this new sequence identified three
new overlapping ESTs (embl/AI417361/AI41, emnew/AI598171/AI5, and embl/
AA0854484/HSAA).
5* end mapping of dAdat1. Rapid amplification of cDNA ends was performed
as previously described (14). One microgram of embryo poly(A)1 mRNA from
D. melanogaster (Clontech) was mixed with DRS3, which is a dAdat1-specific
reverse primer, and reverse transcribed with 200 U of SuperScript II (RNase
H2) reverse transcriptase (Gibco BRL) at 42°C for 50 min. Excess primer was
then removed with a QIAquick nucleotide removal kit (Qiagen) and a poly(G)
tail was added to the 39 end of the first cDNA strand with 40 U of terminal
deoxynucleotide transferase (Pharmacia) for 15 min at 37°C. The tailed cDNA
was amplified with a (dC)13 adapter primer and the reverse primer ADAT1. A
further round of amplification was carried out with the primer DRS2 and the
adapter primer. The final PCR product was subcloned in the T/A cloning vector
pGEM-Teasy (Promega) and sequenced with a Dye Terminator Cycle Sequenc-
ing Ready Reaction kit on an Applied Biosystems 373A sequencer with vector-
specific primers.
Expression of epitope-tagged recombinant dADAT1 protein in Pichia pastoris
and protein purification. The coding sequence of dAdat1 missing the first me-
thionine and the stop codon (2 to 394 amino acids) was amplified by PCR from
clone 12 with primers containing NheI restriction sites at their 59 termini. The
PCR product was subsequently subcloned in the T/A cloning vector pGEM-
Teasy (Promega). The resulting clone, pTE-ADAT, was sequenced, digested
with NheI, and subcloned into the SpeI site in pSK-FLIS6 (33) to express a
recombinant protein with the FLAG epitope tag (Sigma) at the N terminus and
a histidine hexamer at the C terminus. This subclone was digested with NotI and
used for gene replacement of the AOX1 locus in P. pastoris GS115 (Invitrogen).
Twenty-five-milliliter cultures of His1 transformants were grown in buffered
minimal methanol medium and used to make small-scale liquid nitrogen extracts
for expression monitoring. Expression of recombinant dADAT1 was monitored
by immunoblot analysis with anti-dADAT1 polyclonal antiserum (1:1,000) raised
against the deaminase domain of dADAT1 and with an a-FLAG M2 monoclonal
antibody (1:5,000) (Sigma).
For protein purification, all manipulations were carried out at 4°C. The large-
scale protein preparation was performed as previously described (16, 33). The
buffer used was buffer A-80 (50 mM Tris-HCl [pH 7.9], 80 mM KCl, 10%
glycerol, 0.1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride (PMSF),
0.7 mg of pepstatin per ml, and 0.4 mg of leupeptin per ml). Twenty-five milli-
liters of extract supernatant containing 5 to 10 mg of soluble protein per ml was
mixed with Ni21-nitrolotriacetic acid agarose (Ni21-NTA) (Qiagen) that had
been preequilibrated with buffer A-80 according to the manufacturer’s instruc-
tions, poured into a column, washed, and eluted with buffer A-80 containing 250
mM imidazole. Immunoblot analysis of the column fractions with an a-FLAG
M2 monoclonal antibody revealed a band of 48 kDa.
Fractions containing recombinant dADAT1 from the Ni21-NTA column were
pooled, further purified by chromatography on an a-FLAG M2 antibody matrix
(Sigma), and eluted with FLAG peptide (Sigma). A 150-ml bed volume of
anti-FLAG M2 matrix was poured in a minicolumn (diameter, 0.7 cm) and
equilibrated with TKG-150 buffer (50 mM Tris-HCl [pH 7.9], 150 mM KCl, 10%
glycerol, 0.1 mM EDTA [pH 8.0], 0.02% NP-40, 0.1 mM dithiothreitol, 0.5 mM
PMSF, 0.7 mg of pepstatin per ml, and 0.4 mg of leupeptin per ml). The column
was washed with 5 ml of TKG-250 (TKG buffer with 250 mM KCl) and 4 ml of
TKG-50 (TKG buffer with 50 mM KCl). The protein was eluted with TKG-50
containing 50 mg of FLAG-peptide per ml, and 200-ml fractions were collected.
Fractions were frozen in liquid nitrogen and stored at 270°C. Ten microliters of
the fractions was analyzed by electrophoresis on an SDS–12% polyacrylamide
gel, and proteins were stained with Coomassie blue R-250 (Bio-Rad) (see Fig.
3A). For immunoblot analysis with the rabbit anti-dADAT1 serum, 5 ml of the
fractions was electrophoresed on an SDS–10% polyacrylamide gel (see Fig. 3B).
Antiserum preparation. The 600-nucleotide PCR fragment used to screen
cDNA libraries encoded the deaminase domain of dADAT1. This PCR fragment
was also subcloned into the histidine tag expression vector pTrcHisB (Invitrogen)
with the BamHI and HindIII restriction sites (pTrcHisB-DM) to generate a
fusion protein with six histidines at the N terminus. Escherichia coli containing
plasmid pTrcHisB-DM was grown in Superbroth and induced at an optical
density at 600 nm of 1 with 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG)
and allowed to grow for an additional 4 h at 37°C. The bacteria were harvested
by centrifugation, and the overexpressed protein was purified under denaturing
conditions as described by the manufacturer (Qiagen) and chromatographed
over an Ni21-NTA affinity column. The fusion protein was eluted in 5 ml of
buffer C (0.1 M sodium phosphate, 0.01 M Tris-HCl [pH 6.3], 250 mM imidazole,
and 1 M urea). Aliquots of the fractions from the Ni21-NTA affinity column were
analyzed by electrophoresis on an SDS–12% polyacrylamide gel, and proteins
were stained with Coomassie blue. The fusion protein had a molecular mass of
approximately 30 kDa.
A New Zealand White rabbit was injected intradermally with approximately
100 mg of the recombinant fusion protein. The antigen was emulsified with
Specol adjuvant (Central Veterinary Institute, Lelystad, The Netherlands). The
rabbit was given a boost every 4 weeks, and blood was collected from the dorsal
ear vein 2 weeks after each boost.
tRNA adenosine deaminase assay. tRNA was transcribed in vitro with T7
RNA polymerase and [a-33P]ATP and purified as previously described (2, 15).
The tRNA adenosine deaminase assays were performed at 30°C for 1 h with
recombinant dADAT1. The assay was carried out under optimized conditions as
previously described (16); in particular, 200 fmol of a-33P-labelled tRNAs was
incubated with 1 ml of purified recombinant dADAT1 for 45 min at 30°C. One
nanogram of scTad1p was used as a positive control. To measure specific activity
on Bombyx or yeast substrates, 200 fmol of tRNA (4 nM) was used in a 50-ml
reaction mixture with 1 ng of dADAT1 (0.04 nM). The activity unit is as defined
by Auxilien et al. (2) and 1 U of enzyme activity converts 1026 mol of adenosine
to inosine per h under these conditions.
UV cross-linking experiments. The cross-linking experiments were performed
as previously described (30). The reaction mixture was the same as for the
activity assays. Forty-five nanograms of purified recombinant dADAT1 was in-
cubated with 200 fmol of substrate tRNA for 15 min at room temperature in a
10-ml final volume. The reactions were irradiated to 250 mJ in a Stratalinker-
1800 (Stratagene) and subsequently digested with 250 ng of RNase A for 30 min
at 37°C. A total of 2.5 ml of 43 SDS loading buffer (24) was added directly to the
samples. Samples were electrophoresed on an SDS–12% polyacrylamide gel.
Gels were fixed, dried, and exposed overnight on a PhosphorImager screen
(Molecular Dynamics). For cross-linking studies with recombinant scTad1p, ei-
ther 50 or 100 ng of protein was incubated with the tRNAs.
tRNA genes. Yeast and Bombyx mori substrates are described by Gerber et al.
(15). mut 5 was a gift from Henri Grosjean and is as previously described (2).
Whole-mount in situ hybridization. Digoxigenin-labelled sense (T3 RNA poly-
merase and antisense (T7 RNA polymerase) RNA transcripts of dAdat1 from
clone 12 were generated with a Boehringer Mannheim Dig-labelling kit accord-
ing to the manufacturer’s instructions and hybridized to Drosophila embryos
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overnight following standard protocols (49). Hybridized transcripts were de-
tected with an alkaline phosphatase-conjugated anti-digoxigenin Fab fragment
(Boehringer Mannheim), with nitroblue tetrazolium (Sigma) and 5-bromo-4-
chloro-3-indolylphosphate (BCIP) (Sigma) as chromogenic substrates. Embryos
were whole mounted in Canada balsam (Serva) and photographed with an
Olympus 35-mm camera on an Olympus Provus microscope with differential
interference contrast optics.
Nucleotide sequence accession numbers. The nucleotide sequence of dAdat1
encoded by clone 12 has been submitted to the GenBank database; the accession
number is AF192530. The hADAT sequence was submitted previously (28), and
the accession number is AF125188.
RESULTS
Characterization of a Drosophila gene encoding an adeno-
sine deaminase domain. Homology searches with hADAR1
identified an ORF encoding an ADAR-like adenosine deami-
nase domain in a 3-kb subclone of D. melanogaster P1 genomic
clone DS00941 that had been sequenced by the BDGP (Fig. 1).
The sequence conservation in the predicted adenosine deami-
nase domain included the three motifs containing a histidine
and two cysteine residues, proposed to be involved in zinc
coordination at the active site, as well as a conserved glutamate
residue in motif I which is also believed to participate in the
deamination reaction (23, 34). The coding sequence in
DS00941 did not contain any potential dsRNA-binding domain
(47).
The genomic sequence from DS00941 was used to design
PCR primers to amplify a 600-bp DNA fragment encoding this
putative adenosine deaminase sequence from genomic DNA
(Fig. 1), which was then used to screen embryonic cDNA
libraries. Low-stringency Southern blots with this fragment
indicated that the gene is single copy (results not shown). One
long cDNA clone (clone 12) and another shorter clone (clone
H) were isolated, confirming that this ORF is part of a tran-
scribed sequence.
The P1 clone DS00941 is now fully sequenced by the BDGP
and is part of a 2.9-Mb stretch of contiguous sequence in the
Adh region on the left arm of Drosophila chromosome II. The
gene encoding the adenosine deaminase domain is the second
predicted gene product from the centromere distal end of this
82-kb P1 clone and is referred to as BG:DS00941.2 (1). The
relationship between the isolated cDNAs and the structure of
the BG:DS00941.2 transcript as predicted from the genomic
sequence by Drosophila GRAIL and Genefinder programs are
indicated in Fig. 1, together with the 600-nucleotide fragment
that was used as a probe to isolate the cDNAs. Comparison of
cDNA sequences with the genomic DNA sequence revealed
that the cDNA clones are interrupted by a short intron of 57 bp
within the protein coding sequence and by a second short
intron of 54 bp within the 39 untranslated region of the longer
cDNA clone. Clone H begins at base pair 574 of clone 12 and
terminates at a more proximal polyadenylation site. Two dif-
ferent polyadenylation sites are used, one located 30 bp after
the ORF and a second site located 1.8 kb more 39, which
produces a transcript with a long 39 region in which no addi-
tional ORFs can be identified. Both polyadenylation sites are
preceded by a polyadenylation consensus sequence.
Clone 12 encodes an ORF (from nucleotides 23 to 1207)
encoding a protein of 394 amino acids (Fig. 2) that contains a
putative ADAR-type adenosine deaminase domain but lacks a
dsRNA-binding domain. The predicted adenosine deaminase
domain shows 38% identity and 47% similarity to human
ADAR2, whereas the S. cerevisiae Tad1p has 25% identity and
37% similarity to human ADAR2 (Wisconsin Package; best fit,
gap weight 8 and length weight 2) (13). The predicted Dro-
sophila adenosine deaminase domain shows 29% identity and
40% similarity to the S. cerevisiae Tad1 protein.
This was the first gene of the ADAR family identified in
Drosophila and we considered it a candidate enzyme for cata-
lyzing the proposed editing events in the cac and para pre-
mRNAs (18, 36, 44). Since the sequence of the encoded deami-
nase domain resembles vertebrate ADAR2 more than yeast
Tad1p, we initially considered the possibility that the ORF was
the 39 end of a longer mRNA that would also encode dsRNA-
binding domains. We therefore directed considerable effort to
search for cDNAs that could encode a longer protein. Other
embryonic cDNA libraries were screened, and despite the iso-
lation of additional positive clones, none contained ORFs
longer than that of clone 12. Neither amplification of 59 ends
from embryonic cDNA libraries nor 59 rapid amplification of
DNA ends with poly(A)1 RNA from embryos, larvae, or
adults gave any indication of an RNA significantly longer than
clone 12 that could encode additional amino acids on the 59
end. Northern blot analysis of poly(A)1 RNA from embryos
with a fragment encoding the deaminase domain used as a
probe revealed two bands, one of approximately 4.3 kb and a
shorter one of 3 kb, which is the same size as clone 12 (data not
shown). We therefore conclude that the 4.3-kb band must
encode an mRNA with an extended 39 untranslated region.
The genomic sequence upstream of the start of clone 12 con-
tains no good consensus for a TATA box, but there is a con-
sensus for an initiator (Inr) element (27) 15 nucleotides from
the predicted start codon.
A rabbit polyclonal antiserum was raised against the deami-
nase domain. The BamHI-HindIII fragment encoding part of
the deaminase domain was subcloned into the E. coli histidine
tag expression vector pTrcHisB to obtain a fusion protein with
six histidines at the N terminus. This protein was purified and
used for polyclonal antibody production in rabbits. Antiserum
raised against the adenosine deaminase domain recognized a
protein of 43.5 kDa, which is the size predicted from the coding
sequence in clone 12, on immunoblots of Drosophila embry-
onic nuclear extracts (data not shown).
BG:DS00941.2 encodes a Drosophila ADAT that deaminates
adenosine 37 in a silk moth tRNA-alanine substrate. The
FIG. 1. Structure of the dAdat1 gene and encoded protein. (A) Genes and
predicted ORFs carried in the region from 5 to 15 kb from the centromere distal
end of the Drosophila P1 genomic clone DS00941 sequenced by the BDGP. The
telomere is to the left and the centromere is to the right. This schematic is
derived from a CloneView analysis (19) of the P1 sequence, which can be viewed
at the BDGP web site (http://www.fruitfly.org). Sos is a previously characterized
gene, whereas the genes indicated as BG:DS00941.N are predicted from the
genomic sequence. Predicted ORFs are shown as black bars and predicted exons
are shown as white boxes. Bases 9078 to 9776 in this genomic clone showed the
initial homology to an ADAR-like adenosine deaminase domain. cDNA clones
are shown in the enlarged view beneath, and the endpoints of clone 12 on the
genomic sequence are indicated. Exons and introns are drawn to scale, and the
coding sequence is hatched. The cDNAs are depicted in a reverse orientation to
maintain colinearity with DS00941. Asterisks indicate the locations of adenosine
deaminase motifs I, II, and III.
VOL. 20, 2000 DROSOPHILA ADAT1 827
FIG. 2. Multiple sequence alignment showing the Drosophila adenosine deaminase encoded by clone 12, compared to vertebrate ADARs and yeast scTad1p and
spTad1p. The adenosine deaminase motifs containing cysteine and histidine residues that are proposed zinc ligands (#) and a glutamate residue (D) that is thought
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methylotrophic yeast P. pastoris was used to overexpress the
protein encoded by clone 12 so as to determine its function.
Previous work has shown this yeast to be excellent for the
production of active ADARs and ADATs (15, 16, 33). The
coding sequence of clone 12 was subcloned into the P. pastoris
expression vector pSK-FLIS6 to express a fusion protein with
a FLAG epitope at the amino terminus and six histidine resi-
dues at the carboxy terminus. This construct was transformed
into P. pastoris by standard methods. Extracts from trans-
formed cells contain a protein with a molecular mass of 48 kDa
detectable on immunoblots with a-FLAG M2 antibody. This
molecular mass is consistent with the length of the coding
sequence of clone 12 and the N- and C-terminal epitope tags
(results not shown).
Extracts were made from 300-ml cultures grown in methanol
medium. Soluble extract was mixed with Ni21-NTA, poured
into a column, and eluted with 250 mM imidazole. This eluate
was applied to an affinity column bearing the a-FLAG M2
monoclonal antibody, and proteins were eluted with FLAG
peptide. Figure 3A shows SDS-polyacrylamide gel electro-
phoresis of fractions from a FLAG affinity column in which the
proteins have been stained with Coomassie blue. A protein of
48 kDa is present in the eluate fractions, and this protein is
recognized by the antibody raised against the deaminase do-
main (Fig. 3B). Approximately 40 mg of pure dADAT1 was
obtained per 300 ml of starting culture.
Peak fractions containing the 48-kDa protein from the
FLAG affinity column were tested for adenosine deaminase
activity on in vitro-synthesized [a-33P]ATP-labelled tRNAAla
from the insect B. mori (2, 46, 51) or from S. cerevisiae.
scTad1p has been shown to specifically deaminate the adeno-
sine at position 37 in yeast and B. mori tRNAAla (15). The
recombinant 48-kDa Drosophila protein converts adenosine to
inosine in tRNAAla from B. mori with a specific activity of 8.4
U/mg (Fig. 4A, lane 5). Mutated B. mori tRNAAla in which the
adenosine at position 34 has been changed to guanosine has
the same level of adenosine-to-inosine conversion as the wild-
type substrate (lane 6). However, a change from adenosine to
guanosine at position 37 (lane 7) or a double change of cyto-
sine 36 to uridine and adenosine 37 to guanosine (lane 8)
eliminates all adenosine-to-inosine conversion in the Bombyx
tRNA substrate, indicating that it is adenosine 37 and not
adenosine 34 that is deaminated. In contrast, yeast tRNAAla is
not an efficient substrate for the Drosophila enzyme that has a
specific activity of 0.08 U/mg with this substrate (Fig. 4A, lane
3). The location of the inosine formed in the tRNAAla sub-
strates was confirmed by performing reverse transcription PCR
on the reaction products and sequencing the resulting cDNAs
(data not shown). Therefore, the Drosophila clone encodes a
protein that is clearly a functional homolog of scTad1p, and we
have named it Drosophila ADAT1 (dADAT1).
The Drosophila enzyme cannot bind efficiently to the yeast
tRNAAla. UV cross-linking of dADAT1 to [a-33P]ATP-labelled
tRNAAla substrates from B. mori or yeast confirm that
dADAT1 binds much more efficiently to the tRNA from B.
mori (Fig. 4B, lanes 1 and 3). Surprisingly, dADAT1 also binds
to a Bombyx tRNA substrate in which positions 36 and 37 are
mutated (Fig. 4B, lane 2) although less tightly than to the wild
type. The scTad1 protein deaminates both the yeast tRNA
(Fig. 4A) and the B. mori tRNA efficiently (15), and UV
cross-linking experiments confirm that scTad1p binds effi-
ciently to both tRNAAla from B. mori (Fig. 4B, lane 7) and
from yeast (lane 9).
We also tested whether purified recombinant dADAT1
could deaminate adenosine to inosine on extended dsRNA,
but no conversion was observed (results not shown), suggesting
that dADAT1 has no role in pre-mRNA editing.
Expression of dAdat1 transcripts in Drosophila embryos.
Digoxigenin-labelled sense or antisense dAdat1 RNA probes
derived from clone 12 were hybridized to Drosophila embryos.
As expected, a signal could be visualized only with the anti-
sense dAdat1 probe. The expression patterns observed with
antisense probes from clone H and clone 12 were identical, and
those obtained with clone 12 are shown in Fig. 5. A strong
overall staining was detected at the blastoderm stage (Fig. 5A),
suggesting that dAdat1 mRNA is maternally provided, since no
zygotic transcripts are expressed at this early stage. Zygotic
expression was very strong during germ band extension, espe-
cially in the mesoderm and neuroectoderm (Fig. 5B). From
germ band retraction onwards, high levels of transcripts were
confined to the central nervous system and transcript levels
remained high in the entire brain and ventral nerve cord
throughout late embryogenesis (Fig. 5C).
Isolation of a human ADAT gene and comparison with Dro-
sophila Adat1 reveals metazoan ADATs with adenosine deami-
nase domains surprisingly similar to ADARs involved in pre-
mRNA editing. Database searches with S. cerevisiae ADAT1
identified a partial sequence of a potential human homolog in
the Washington University EST database. The clone from
which this sequence derived was obtained, and additional se-
quence information for the amino-terminal half of this protein
was determined (see Materials and Methods). The resulting
sequence revealed an ORF with homology over its entire cod-
ing sequence to Drosophila Adat1, which is not surprising con-
sidering that tRNAAla species from B. mori and humans are
very similar (6). While this paper was in preparation, Maas et
al. (28) reported the characterization of the human ADAT1
and showed that this protein deaminates adenosine 37 of hu-
man tRNAAla. The amino acid sequence of this human ADAT
is included in the multiple sequence alignment shown in Fig. 2.
Both human and Drosophila ADATs are more similar to aden-
osine deaminase domains of vertebrate ADARs than to the
yeast ADATs.
To examine phylogenetic relationships among adenosine
deaminase domains, ADAR and ADAT sequences were re-
covered from databases and multiple sequence alignments
were performed with the Wisconsin Genetics Computer Group
(GCG) Pileup program (13). The most consistent alignments
involve residues close to the histidine and cysteine residues of
deaminase motifs I, II, and III (Fig. 2). All ADAT proteins are
approximately the same size and there is homology among the
proteins over the full length of the sequences that is observed
when lower gap insertion and extension penalties are used in
the Pileup program. Aligned sequences were truncated to re-
to be involved in proton transfer in the deaminase active site are indicated. A potential RNA recognition region flanking the third cysteine of the deaminase motif is
underlined. The human ADAT (hADAT) has 93 residues more than dADAT1 between deaminase motifs II and III, and this number of amino acids has been removed
from hADAT between the sequences EDQP and SAKV after residue 157 (p). The DDBJ, EMBL, and GenBank accession numbers of the sequences are as follows:
human hADAR1, U10439; human hADAR2a (a shorter protein lacking an Alu element inserted between deaminase motifs II and III), U82120; S. cerevisiae scTad1p,
AJ007297; S. pombe spTad1p, AL021748; dADAT1, AF192530; and hADAT, AF125188. The alignment was generated with the Wisconsin GCG Pileup program with
a gap penalty of 3 and a gap extension penalty of 1 and edited by using Lineup. The order in which sequences are presented is determined by the program according
to their similarity to each other.
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move dsRNA-binding domain sequences from the ADAR
genes, and multiple sequence alignments of adenosine deami-
nase domains were used to generate phylogenetic trees with
the PAUP (phylogenetic analysis using parsimony) (48) pro-
gram in the Wisconsin GCG program package (13).
Many adenosine deaminase domain trees generated from
Pileup alignments made with different gap insertion and ex-
tension penalties have topologies similar to that shown in Fig.
6. Human ADAT and Drosophila ADAT1 are closely related
and their relationship to S. cerevisiae Tad1p and Schizosaccha-
romyces pombe Tad1p pair is distant. The ADAR genes are
always found to branch from the ADAT line. Among the
ADARs, human ADAR2 and the putative Drosophila ADAR
N35H14 (accession no. AL035207) are closely related, while
the branching order of the other two ADARs is less consistent.
In order to obtain the best possible alignment with fewer gaps
and with aligned residues representing true homologies, a re-
gion around the conserved deaminase motifs was selected and
aligned more stringently to produce the tree shown in Fig. 6.
DISCUSSION
An enzymatic activity capable of converting adenosine to
inosine in dsRNA is present in D. melanogaster (10). To find a
gene encoding this activity, we performed a homology search
with hADAR1. An ORF was found that had high sequence
homology to the deaminase domain of hADAR1. We isolated
this gene and showed that it encoded an adenosine deaminase
that specifically converts adenosine to inosine at position 37,
adjacent to the anticodon in B. mori tRNAAla(IGC). We have
named this gene dAdat1 because of its homology to the yeast
scADAT1.
The dAdat1 gene is located 2 to 7 kb centromere distally to
Son of sevenless (Sos) (7, 43) in the Adh region on the left arm
of chromosome II. It is within a 2.9-Mb stretch of contiguous
sequence that has been correlated with extensive sets of dele-
tions and point mutations (1). dAdat1 is flanked centromere
distally by a predicted carbonate dehydratase gene (BG:
DS00941.1) and centromere proximally by a predicted protea-
some subunit gene (BG:DS00941.3). The predicted carbonate
dehydratase coding sequence is fully contained within the 39
untranslated region of the longer dAdat1 cDNA clone 12.
dAdat1 and the predicted proteasome subunit gene are both
present on genomic fragments that contained Sos and 10 kb of
upstream DNA that was transformed into Drosophila to iden-
tify the correct mRNA for Sos by genetic rescue (7, 43).
Drosophila ADAT1 binds and deaminates tRNAAla from B.
mori 100-fold more efficiently than the tRNAAla from S. cer-
evisiae (data not shown). The yeast Tad1p deaminates A37
more effectively in yeast tRNAAla than in the tRNAAla from B.
mori (15). Each ADAT shows preference for tRNAAla from
the same or more closely related organisms.
The tRNAAla from B. mori (Fig. 3C) that was used as a
substrate for dADAT1 in this study is a tRNA expressed spe-
cifically in the silk moth salivary gland, where alanine is incor-
porated into the silk fibroin protein (46, 51). Wild-type and
mutant forms of this tRNA substrate have been used in earlier
studies of adenosine-to-inosine conversion and other modifi-
cations in tRNAAla (2, 17). This salivary gland-specific
tRNAAla differs by one base at position 40 in the anticodon
arm from the constitutive silk moth tRNAAla, which also has
an inosine at position 37 (Fig. 4C). One gene encoding a
tRNAAla has been characterized in Drosophila (12), but it is
not known whether some Drosophila tRNAs have tissue-spe-
cific expression similar to that found for the silk moth tRNAAla
genes (46). It is not known if the conversion of adenosine to
inosine at position 37 in tRNAAla is always complete, and the
degree of conversion could vary in different tissues.
The significance of adenosine-to-inosine conversion adja-
cent to the anticodon in tRNAAla(IGC) is not known. Yeast
tad1 mutants are viable and contain unmodified adenosine 37
in their tRNAAla species (15). No deletion in dAdat1 is avail-
able that only removes dAdat1 and not neighboring genes.
Almost all the lethal mutations that have been found near Sos
have been assigned to genes that were previously known or
that have been identified in the genomic sequence (1). None of
the known lethal mutations are in dAdat1. The effect of loss of
function in Drosophila Adat1 therefore cannot yet be assessed.
Transcripts of dAdat1 are produced by nurse cells and
loaded into the egg before fertilization (Fig. 5). Many mRNAs
encoding proteins that will be required for transcription and
translation during the early stages of embryonic development
are provided in this way. Zygotic cells throughout the embryo
contain dAdat1 mRNA in germ band-extended embryos, but
most of the expression in later germ band-retracted embryos is
in the central nervous system. Much of the mesoderm and
ectoderm is larval tissue that will be histolyzed at metamor-
phosis; thus, it is possible that early dAdat1 expression is suf-
ficient for the remaining lifetime of these cells. The high level
of expression in the nervous system is intriguing. It is possible
that dAdat1 activity is ubiquitous, even though the transcript
expression pattern observed by in situ hybridization is concen-
trated in the nervous system. Considering the high degree of
homology between dADAT1 and the ADAR enzymes, it is
curious that the embryonic expression of dAdat1 is found in the
central nervous system and is reminiscent of rRED2 expres-
sion, which is confined to the brain (31).
It is surprising that Drosophila ADAT1 shows a greater
similarity to ADARs involved in pre-mRNA editing than to
the yeast Tad1 proteins, considering that these proteins have
very different substrates (Fig. 2). Based on functional group-
ings, dADAT1 might have been expected to resemble S. cer-
evisiae Tad1p more than vertebrate ADARs. A human ADAT
gene also exhibits similarity to dAdat1 and to vertebrate
FIG. 3. Purification of recombinant Drosophila adenosine deaminase from P.
pastoris. (A) Fractions from a FLAG affinity column eluted with a FLAG peptide
were electrophoresed on an SDS–10% polyacrylamide gel, and proteins were
stained with Coomassie blue. L, load; FT, flowthrough, W, wash. Molecular
masses are indicated on the left. (B) Immunoblot analysis of fractions from the
FLAG affinity column with antiserum raised against Drosophila ADAT1. Mo-
lecular masses are indicated on the left. Numbers at the top of the lanes are
eluate fraction numbers; numbers at the bottom are lane numbers.
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ADARs. It is possible that this similarity between dADAT1
and ADARs reflects a role for dADAT1 in editing pre-mRNA.
However, such an activity is unlikely, since recombinant
dADAT1 protein cannot convert adenosine to inosine in
dsRNA substrates. An ADAR-like gene (N35H14) with two
dsRNA-binding domains has been sequenced by the European
Drosophila Genome Project and independently cloned from
Drosophila (R. Reenan, personal communication). The protein
encoded by this gene converts adenosine to inosine in dsRNA
substrates (M. O’Connell and R. Reenan, unpublished results)
and is a strong candidate for catalyzing editing in the cac and
para pre-mRNAs (18, 36, 44).
One major question is how the ADAR family of enzymes
recognize their target adenosines in pre-mRNA. The dsRNA-
binding domains show little sequence specificity, recognizing
continuous dsRNA structures (41). With the emergence of the
homologous ADAT family of enzymes having a deaminase
domain that binds to specific tRNA, it seems probable that the
adenosine deaminase domain of ADARs contributes more
than was previously anticipated to RNA binding and hence to
substrate recognition. It has previously been shown that aden-
osine deaminase domains alone are not sufficient for editing by
ADARs in vitro (25, 29), but it has not been determined if the
deaminase domain alone can bind to RNA. A domain of
ADAR corresponding to the region of ADAT homology can
now be expressed in recombinant form. Detailed RNA-binding
studies can then be performed in vitro to determine if indeed
the deaminase domain alone can bind to pre-mRNA substrates
and contribute to the target specificity of these enzymes.
ADATs are likely to have a higher affinity for RNA sub-
strates than an isolated ADAR adenosine deaminase domain,
since ADARs probably depend on their dsRNA-binding do-
mains for RNA affinity. It is interesting therefore to compare
ADAR and ADAT sequences around the putative zinc-chelat-
ing residues. The number of residues between deaminase mo-
tifs I and II is well conserved, whereas the number of residues
between deaminase motifs II and III differs (22). Structural
adjustments near deaminase motif III could be associated with
changes in the target specificity of adenosine deaminase do-
mains. A cluster of positively charged residues is well con-
served between dADAT1, hADAT1, and the yeast ADATs in
the region amino terminal to deaminase motif III (Fig. 2) (28).
This cluster of positively charged residues could be a region of
the protein that contacts RNA.
This region of sequence similarity among ADATs has also
been noted by Maas et al. (28) in an alignment in which all
hADAT residues between deaminase motifs II and III were
included. Due to the variability in the number of residues
between motifs II and III, sequence alignments that include
this region can have different gaps and therefore highlight
different blocks of homology. In addition to the ADAT signa-
ture sequence near deaminase motif III, Maas et al. (28) ob-
served an ADAR specific signature sequence 19 residues
amino terminal to the ADAT signature sequence. However,
FIG. 4. Recombinant Drosophila adenosine deaminase binds to and modifies
tRNAAla. (A) tRNA-specific adenosine deaminase assay with peak fractions
from an a-FLAG M2 antibody column. Different tRNAAla species were labelled
with [a-33P]ATP. The extracts used were recombinant scTad1p (lanes 1 and 2)
and recombinant dADAT1 (lanes 3 to 8). The substrates used are indicated
above each lane. Abbreviations: y, yeast; B.m., B. mori; wt, wild-type tRNAAla;
A34G, G34 instead of A34; A37G, G37 instead of A37; CA3637UG, substrate has
a double change of C36 to U36 and A37 to G37. (B) UV cross-linking of dADAT1
and scTad1p to [a-33P]ATP-labelled tRNA. The reaction mixtures were irradi-
ated, digested with RNase A, and electrophoresed on an SDS–12% polyacryl-
amide gel. Lanes 1 to 5 each contained 45 ng of recombinant dADAT1, and lanes
7 to 11 each contained 100 ng of recombinant scTad1p. Lane 6 had no protein.
The abbreviations for the substrates are the same as in panel A. Ser, tRNASer;
mut5, yeast tRNAAsp with tRNAArg anticodon loop (2). (C) Sequence differ-
ences between tRNAAla from yeast and B. mori. The 19-base differences between
the two tRNAAla species are indicated. The silk gland-specific tRNAAla from B.
mori contains U instead of C at position 40.
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visual inspection of many different computer-generated align-
ments suggests that this ADAR-specific signature could be a
variant of the ADAT signature sequence which has been
moved 19 residues further from deaminase motif III. Residues
178 to 189 of hADAR1 (LRTKvenGEgTi) (Fig. 2), which are
conserved among ADARs, resemble residues 176 to 187 of
dADAT1 (LRTKpgrGErT1), which are conserved among
ADATs. It is possible that the evolution of ADATs to ADARs
involved an insertion close to motif III that could have affected
target sequence recognition.
It is possible that an ADAT signature sequence is only vis-
ible close to the active site of the enzyme, as other tRNA-
protein contacts may involve multiple weakly conserved sites
over the entire protein and therefore be difficult to recognize.
One or more of the 19 differences between tRNAAla from S.
cerevisiae and B. mori have a more significant effect on the
activity of dADAT1 than on Tad1p, suggesting that these pro-
teins may not make all RNA contacts in precisely the same
manner.
Pre-mRNA editing may have evolved when an original
ADAT acquired dsRNA-binding domains and a new set of
targets in pre-mRNA. An interesting interpretation of se-
quence homologies and of the phylogenetic tree shown in Fig.
6 would be the following. (i) Tad1p does not encode an essen-
tial function in yeast, and the sequence conservation with
metazoan ADATs is correspondingly low and focused on the
zinc-chelating residues in the deaminase domain. (ii) ADARs
evolved from ADATs after the divergence of fungal and meta-
zoan lines. (iii) Double-stranded RNA-binding domains may
have been added to an ADAT gene after a gene duplication
event, and such a protein might have retained ADAT function
for a period until it evolved to recognize a more ADAR-like
range of RNA targets. Other evolutionary scenarios can be
envisaged, however; Drosophila and human ADAT genes ap-
pear to be more closely related than yeast TAD1 to a precursor
gene that gave rise to the ADAR family. Studies on the rec-
ognition of tRNA substrates by Drosophila or human ADAT1
should help to explain how pre-mRNA editing evolved and
how target sequences are recognized in pre-mRNA editing.
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